{
    "nct_id": "NCT06123286",
    "official_title": "An Open Label, Randomized, Waitlist Controlled Trial of Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms",
    "inclusion_criteria": "* Breast cancer diagnosis (Stage I-III) with any hormonal status.\n* Females aged ≥ 18 years.\n* Currently receiving AI therapy.\n* BMI ≥ 27.\n* Clinical diagnosis of AIMSS.\n* Omega-3 Index &lt;8%.\n* Average joint pain score ≥ 4 on the Brief Pain Inventory (BPI) within 7 days of enrollment.\n* Written informed consent obtained from subject and ability and willingness of subject to comply with the requirements of the study.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Current use of anticoagulant medications (Including but not limited to Warfarin, Lovenox, Eliquis, Xarelto).\n* Allergy to cherries or fish/fish products.\n* Lifetime history of rheumatoid arthritis and/or inflammatory joint diseases (Including but not limited to reactive arthritis, ankylosing spondylitis, and psoriatic arthritis).\n* Uncontrolled diabetes mellitus as determined by treating physician (with or without the use of glucose lowering medications and/or insulin).\n* Lifetime history of stroke or transient ischemic attacks.\n* New use or dose change of oral or topical analgesics in the previous 14 days. (Including but not limited to opioids, non-steroidal anti-inflammatories, acetaminophen, SNRI's, SSRI's, gabapentinoids, tricyclic antidepressants, and muscle relaxants).\n* Oral or intra-articular steroid use in the previous 30 days (Including but not limited to dexamethasone, prednisone, methylprednisolone, triamcinolone, hydrocortisone).\n* History of joint fracture or surgery of the symptomatic joint in the previous 6 months.",
    "miscellaneous_criteria": ""
}